Trials / Unknown
UnknownNCT03741192
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Brain Sentinel · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, randomized, prospective study of the impact on healthcare utilization of a surface Electromyography (sEMG) based seizure monitoring and alerting system for Veterans with seizures with upper extremity motor involvement, that are refractory to three or more antiepileptic drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SPEAC System | Surface Electromyography (sEMG) based seizure monitoring and alerting system |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-01-01
- Completion
- 2026-01-01
- First posted
- 2018-11-14
- Last updated
- 2019-07-10
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03741192. Inclusion in this directory is not an endorsement.